"Achieving MDR CE Mark is a significant milestone in Radformation's mission to advance global cancer care," said Kurt Sysock, CEO at Radformation. "We are excited to bring our solutions to CE mark ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, potentially improving survival and expanding treatment options. A novel approach ...